Cooley advised Turnstone Biologics, a clinical-stage biotechnology company, on its upsized $80 million initial public offering. Lawyers Div Gupta, Ryan Sansom, Lila Hope, Alexa Smith and Valerie Sapozhnikova led the Cooley team advising Turnstone.